Total Payments
$10,533
2024 Payments
$222.27
Companies
53
Transactions
699
Medicare Patients
2,639
Medicare Billing
$331,276
Payment Breakdown by Category
Food & Beverage$9,213 (87.5%)
Travel$1,025 (9.7%)
Education$270.77 (2.6%)
Other$24.02 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,213 | 680 | 87.5% |
| Travel and Lodging | $1,025 | 3 | 9.7% |
| Education | $270.77 | 14 | 2.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24.02 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $1,380 | 15 | $0 (2021) |
| EMD Serono, Inc. | $802.05 | 75 | $0 (2020) |
| GENZYME CORPORATION | $733.45 | 41 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $713.81 | 49 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $683.03 | 42 | $0 (2021) |
| Biogen, Inc. | $666.88 | 37 | $0 (2021) |
| ABBVIE INC. | $549.26 | 48 | $0 (2024) |
| Genentech USA, Inc. | $393.73 | 33 | $0 (2020) |
| Allergan, Inc. | $381.74 | 43 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $361.77 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $222.27 | 19 | ABBVIE INC. ($190.49) |
| 2022 | $23.26 | 1 | ABBVIE INC. ($23.26) |
| 2021 | $1,039 | 69 | Teva Pharmaceuticals USA, Inc. ($201.03) |
| 2020 | $727.16 | 40 | EMD Serono, Inc. ($96.58) |
| 2019 | $1,906 | 113 | Novartis Pharmaceuticals Corporation ($204.17) |
| 2018 | $2,625 | 185 | Biogen, Inc. ($331.35) |
| 2017 | $3,989 | 272 | LivaNova USA, Inc. ($1,248) |
All Payment Transactions
699 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Lilly USA, LLC | EMGALITY (Drug), KISUNLA | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Neuroscience | ||||||
| 09/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Rare Disease | ||||||
| 03/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.19 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: NEUROSCIENCE | ||||||
| 01/14/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/22/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.79 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 556 | 775 | $283,785 | $76,775 |
| 2022 | 8 | 591 | 718 | $228,055 | $74,349 |
| 2021 | 11 | 658 | 773 | $256,625 | $82,513 |
| 2020 | 12 | 834 | 1,016 | $368,320 | $97,639 |
Total Patients
2,639
Total Services
3,282
Medicare Billing
$331,276
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 224 | 359 | $104,469 | $30,153 | 28.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 130 | 130 | $62,920 | $14,565 | 23.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 88 | 170 | $39,100 | $12,287 | 31.4% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 56 | 56 | $46,088 | $11,388 | 24.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 27 | $11,475 | $3,381 | 29.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 20 | 20 | $11,400 | $3,107 | 27.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 13 | 13 | $8,333 | $1,895 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 194 | 274 | $64,596 | $24,840 | 38.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 158 | 158 | $56,942 | $18,167 | 31.9% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 52 | 52 | $42,796 | $11,341 | 26.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 67 | 80 | $18,400 | $6,221 | 33.8% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 56 | 87 | $12,789 | $4,361 | 34.1% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 25 | 25 | $16,025 | $4,072 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 31 | $10,237 | $3,488 | 34.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 11 | 11 | $6,270 | $1,859 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 239 | 297 | $88,581 | $28,351 | 32.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 100 | 100 | $41,040 | $12,580 | 30.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 72 | 74 | $42,328 | $11,924 | 28.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 42 | 43 | $13,872 | $6,155 | 44.4% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2021 | 22 | 22 | $16,396 | $5,372 | 32.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 37 | 52 | $12,492 | $4,238 | 33.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 32 | 50 | $14,850 | $4,156 | 28.0% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 14 | 14 | $8,896 | $2,896 | 32.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 33 | 36 | $4,812 | $2,588 | 53.8% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Office | 2021 | 31 | 47 | $7,164 | $2,480 | 34.6% |
About Dr. Siddhartha Varma, M.D
Dr. Siddhartha Varma, M.D is a Neurology healthcare provider based in Matthews, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1598920225.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Siddhartha Varma, M.D has received a total of $10,533 in payments from pharmaceutical and medical device companies, with $222.27 received in 2024. These payments were reported across 699 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($9,213).
As a Medicare-enrolled provider, Varma has provided services to 2,639 Medicare beneficiaries, totaling 3,282 services with total Medicare billing of $331,276. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Neurology
- Location Matthews, NC
- Active Since 07/22/2008
- Last Updated 12/08/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1598920225
Products in Payments
- VNS Therapy (Device) $1,345
- Rebif (Biological) $543.94
- AUBAGIO (Drug) $479.86
- OCREVUS (Biological) $393.73
- TROKENDI XR (Drug) $342.60
- TECFIDERA (Drug) $338.18
- GILENYA (Drug) $333.06
- TYSABRI (Biological) $296.05
- APTIOM (Drug) $288.44
- Briviact (Drug) $270.83
- Gamunex-C (Biological) $266.28
- COPAXONE (Drug) $264.46
- LEMTRADA (Drug) $253.59
- UBRELVY (Drug) $230.26
- ACTHAR (Biological) $228.81
- NORTHERA (Drug) $224.70
- SOLIRIS (Drug) $194.35
- Aimovig (Biological) $193.76
- QULIPTA (Drug) $185.14
- NURTEC ODT (Drug) $176.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.